Robert J Gould
Director at Fulcrum Therapeutics, Inc. (FULC)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $667K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 4SEC | FULCFulcrum Therapeutics, Inc. | Sell Plan | 15,000469,864 held (−3%) | $10.87 | $163K | -66.4% |
| Feb 4SEC | FULCFulcrum Therapeutics, Inc. | Sell Plan | 15,000454,864 held (−3%) | $10.72 | $161K | -66.0% |
| Jan 6SEC | FULCFulcrum Therapeutics, Inc. | Sell Plan | 15,000469,864 held (−3%) | $11.87 | $178K | -69.3% |
| Nov 21SEC | FULCFulcrum Therapeutics, Inc. | Sell Plan | 15,000484,864 held (−3%) | $11.03 | $165K | -66.9% |
- Sell
Director Robert J Gould sold $163K of FULC at $10.87 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Robert J Gould sold $161K of FULC at $10.72 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Robert J Gould sold $178K of FULC at $11.87 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Robert J Gould sold $165K of FULC at $11.03 — pre-scheduled 10b5-1 plan sale.